Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Encoded Therapeutics to Present New Data for CNS Gene Therapy Programs at the ASGCT 28th Annual Meeting
-
Shape Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy 28th Annual Meeting
-
Edgewater Wireless Joins CHIPS North Executive Summit to Share Advances in Wi-Fi Spectrum Slicing
-
NaaS Technology Inc. Announces Completion of ADS Ratio Change
-
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
-
Tessera Therapeutics to Present New Data Across Preclinical Programs for its Gene Writing™ and Delivery Platforms at the American Society of Gene and Cell Therapy 28th Annual Meeting
-
Bakkt Schedules Conference Call to Discuss First Quarter 2025 Results
-
Macerich Declares the Quarterly Dividend on Its Common Shares
-
Lincoln Electric to Present at the Oppenheimer 20th Annual Industrial Growth Conference
-
Customers Bancorp, Inc. Declares Quarterly Cash Dividend on Its Series E and Series F Preferred Stock
-
Triton International Declares Quarterly Dividends on Preference Shares
-
Archer To Report First Quarter 2025 Operating Update and Financial Results on May 12, 2025
-
iHeartMedia, Inc. to Report Quarterly Financial Results on May 12, 2025
-
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
-
SAIHEAT Limited Reports Audited Financial Results for the Year Ended December 31, 2024
-
Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
-
Phoenix Asia Holdings Limited Announces Closing of Its Initial Public Offering
-
Heritage Distilling Co. Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance
-
Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting
-
ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of ORIC-944 as a Best-in-Class PRC2 Inhibitor for the Treatment of Prostate Cancer at the 2025 American Association for Cancer
-
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
-
iTeos Reports First Quarter 2025 Financial Results and Provides Business Updates
-
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
-
Fractyl Health to Present Compelling Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025
-
Shape Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy 28th Annual Meeting
-
Axovia Therapeutics Announces Three Upcoming Poster Presentations at ASGCT
-
420 with CNW — How Marijuana Descheduling or Rescheduling Would Impact the Industry
-
Macerich Declares the Quarterly Dividend on Its Common Shares
-
Spur Therapeutics Announces Oral and Poster Presentations Highlighting Data from Clinical and Preclinical Programs at Upcoming ASGCT Annual Meeting
-
CORRECTION FROM SOURCE: KPMG Acquires Metaphor's Technology Platform to Accelerate AI Adoption and Data Management
-
UFP Industries Announces First Quarter 2025 Results
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Light & Wonder, Inc. Investors to Inquire About Securities Class Action Investigation - LNW
-
Hamilton Wingo Trial Lawyers Named Among Dallas' Best for Personal Injury Lawsuits
-
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Unisys Corporation Investors to Inquire About Securities Class Action Investigation - UIS
-
Welltower Issues Business Update
-
Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference
-
Portillo’s Announces Plan to Further Strengthen Board Through Cooperation Agreement with Engaged Capital
-
Gladius Global Advisors Announces Manny Abin as CEO, Bringing Asset Management Expertise and Innovation to the Table
-
UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS
-
Ebang International Reports Financial Results for Fiscal Year 2024
-
New Poll: Trump’s First 100 Days Leave Latino 2024 Voters Worried, Angry, and Ready for Accountability
-
ROSEN, A LEADING LAW FIRM, Encourages Canopy Growth Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CGC
-
SEABOARD CORPORATION REPORT OF EARNINGS AND DIVIDEND DECLARATION
-
QUBT DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Quantum Computing Inc. Investors to Secure Counsel Before Important April 28 Deadline in Securities Class Action - QUBT
-
Meet the Books Every Parent Is Raving About: Judi Marxer's Latest Stories Are Instant Classics!
-
Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock
-
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES 2025 FIRST QUARTER FINANCIAL RESULTS
-
Cohen & Company Sets Release Date for First Quarter 2025 Financial Results
-
Valmont Board Declares Quarterly Dividend
-
COPT Defense Executes Two Investment Leases in Redstone Gateway Totaling 55,000 SF, Bringing Total Portfolio Year-to-Date Investment Leasing to 103,000 SF
